TABLE 1.

Clinicopathological features of lung adenocarcinoma (LUAD) patients and serine/threonine kinase 16 (STK16) expression in hospital cohort 2

Clinicopathological parameters	STK16 expression		P value
	Low (No. 48)	High (No. 65)
Age
≤55	20	35	.2004
>55	28	30
Sex
Female	22	38	.1836
Male	26	27
Size (cm)
≤4	36	32	.0057
>4	12	33
Smoking status
Never	21	29	.9271
Former and current smokers	27	36
Tumor stage
I	23	11	.0027
II	16	26
III	6	20
IV	3	8
Spinal metastases
No	27	23	.0273
Yes	21	42

P < .05 represents statistical significance (χ²‐test).